REQUEST A DEMO
Total
USD $0.00
Search more companies

Alpha Therapeutics Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Alpha Therapeutics Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Alpha Therapeutics Private Limited is an unlisted company, incorporated on 17/01/2006. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24230GJ2006PTC047526 and registration number is 047526. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
869/1, Atpl House, Sarkhej Bavla Highway, Rajoda,
Ahmedabad; Gujarat; Postal Code: 382220

Contact Details: Purchase the Alpha Therapeutics Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Alpha Therapeutics Private Limited report to view the information.
Registered Capital:
Purchase the Alpha Therapeutics Private Limited report to view the information.
Incorporation Date:
January 17, 2006
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Alpha Therapeutics Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
0.48%
Total operating revenue
0.39%
Operating profit (EBIT)
-10.57%
EBITDA
10.65%
Net Profit (Loss) for the Period
-10.57%
Total assets
10.88%
Total equity
3.98%
Operating Profit Margin (ROS)
-0.08%
Net Profit Margin
-0.08%
Return on Equity (ROE)
-1.48%
Debt to Equity Ratio
-4.27%
Quick Ratio
0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?